Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor
US-11166995-B2 · Nov 9, 2021 · US
This page is not indexed by search engines while we improve data quality.
Genomidea Inc patents
Genomidea Inc holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 0 |
| First publication | Sep 12, 2019 |
| Latest publication | Nov 9, 2021 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Novel therapeutic agent for prionoid diseases
US-2019358276-A1 · Nov 28, 2019 · US
Anti-cancer agent comprising HVJ-E and CXCL2
US-10441613-B2 · Oct 15, 2019 · US
Anticancer agent comprising hvj-e and immune checkpoint protein inhibitor
US-2019275091-A1 · Sep 12, 2019 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor
US-11166995-B2 · Nov 9, 2021 · US
Novel therapeutic agent for prionoid diseases
US-2019358276-A1 · Nov 28, 2019 · US
Anti-cancer agent comprising HVJ-E and CXCL2
US-10441613-B2 · Oct 15, 2019 · US
Anticancer agent comprising hvj-e and immune checkpoint protein inhibitor
US-2019275091-A1 · Sep 12, 2019 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |